Antimicrobial Agents and Chemotherapy · 2022 · 11 citations · 28 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceMedical MicrobiologyMicrobial PathogenesisAntibacterial ResistanceAntibiotic ResistanceAntibiotic Resistance GeneticsAntibiotic Resistance MechanismsBeta-lactam ResistanceMechanisms Of Antimicrobial ResistanceBeta-lactamase GenesBeta-lactamase Inhibitor ResistanceBeta-lactamase InhibitorsBeta-lactamase Mediated ResistanceMortality RatesPseudomonas Aeruginosa Resistanceβ-Lactam Antibiotics
Metallo-β-lactamase (MBL)-producing Pseudomonas aeruginosa is increasingly reported worldwide and usually causes infections with high mortality rates. Aztreonam/avibactam is a β-lactam/β-lactamase inhibitor (BLBLI) combination that is under clinical trials.
28
Roman Jaeschke, Joel Singer, Gordon Guyatt · Controlled Clinical Trials · 1989 · 4.9K citations
Tung T. Hoang, RoxAnn R. Karkhoff-Schweizer, Alecksandr Kutchma et al. · Gene · 1998 · 2K citations